The Effects of EGFR Inhibition on Pulmonary Arterial Hypertension Associated with Systemic SclerosisA phase II open-label safety and efficacy study. - EGFR Inhibition in SSc-PAH The Effects of EGFR Inhibition on Pulmonary Arterial Hypertension Associated with Systemic Sclerosis ...
The Effects of EGFR Inhibition on Pulmonary Arterial Hypertension Associated with Systemic SclerosisA phase II open-label safety and efficacy study. - EGFR Inhibition in SSc-PAH The Effects of EGFR Inhibition on Pulmonary Arterial Hypertension Associated with Systemic Sclerosis ...
Pulmonary arterial hypertension associated with systemic sclerosis